nimodipine has been researched along with Hypertension, Pulmonary in 1 studies
Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.
Hypertension, Pulmonary: Increased VASCULAR RESISTANCE in the PULMONARY CIRCULATION, usually secondary to HEART DISEASES or LUNG DISEASES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A case is reported in which intravenous nimodipine therapy was associated with severe acute pulmonary hypertension in a patient with a subarachnoid haemorrhage." | 3.68 | Pulmonary vasoconstriction following intravenous nimodipine. ( Lovell, AT; Smith, M, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lovell, AT | 1 |
| Smith, M | 1 |
1 other study available for nimodipine and Hypertension, Pulmonary
| Article | Year |
|---|---|
Pulmonary vasoconstriction following intravenous nimodipine.
Topics: Humans; Hypertension, Pulmonary; Male; Middle Aged; Nimodipine; Pulmonary Artery; Subarachnoid Hemor | 1992 |